Biogen to acquire RayThera for $1 billion
Biogen to acquire RayThera for $1 billion June 17 (Reuters) - Biogen BIIB.O said on Wednesday it would acquire drug discovery company RayThera for $1 billion, including milestone payments.
(Reporting by Ananya Palyekar in Bengaluru)
Recent news on Biogen
See all newsUS RESEARCH ROUNDUP-Autodesk, Metlife, Rollins
Brief: Biogen Says DZP Plus Soc Meets Primary Endpoint Of BICLA Response At Week 48
Brief: Biogen Provides Update On Private Payer Coverage For Zurzuvae™ (Zuranolone)
US RESEARCH ROUNDUP-Eli Lilly, General Dynamics, S&P Global
US RESEARCH ROUNDUP-Baker Hughes, Brinker International, GE Vernova